Infection Prevention Issues Unique to Newborns and the Neonatal Intensive Care Unit



Infection Prevention Issues Unique to Newborns and the Neonatal Intensive Care Unit


Matthew Linam

Omayma Amin



Although many of the fundamental principles of infection prevention in adult healthcare settings overlap with those in pediatric healthcare settings, there are a number of unique features and risk factors associated with the care of neonates that are different and are worth highlighting. Hospitalized newborns present unique challenges to preventing healthcare-associated infections (HAIs). This is especially true in the neonatal intensive care unit (NICU). While advances in newborn intensive care have permitted the survival of low birth weight and sick infants, lifesaving, invasive therapies and prolonged hospitalizations place these infants at risk for infection. HAIs contribute substantially to morbidity and mortality in hospitalized neonates.1,2,3

Neonatal humoral and adaptive immunity is immature, resulting in impaired ability to combat infections. In addition, premature infants have underdeveloped skin and mucous membranes that serve as poor barriers to colonizing pathogens. Immaturity of natural barriers and the immune system also impacts prevention strategies such as chlorhexidine gluconate (CHG) bathing and immunization practices for this population. Neonates also are unable to communicate, which creates challenges identifying signs and symptoms of HAIs and hampers the ability to effectively communicate prevention behaviors. This chapter will build on effective general infection prevention practices by providing a context of neonate-specific risk factors and summarizing how those differences lead to specialized prevention strategies.


RISK FACTORS FOR INFECTION


Immunologic Immaturity

Neonates have underdeveloped immune systems and defects in structural defenses that result in increased susceptibility to infection. This is especially true in the neonate born prematurely. The skin, for example, normally provides a mechanical barrier between the host and the environment. In infants born before 32 weeks of gestation, the stratum corneum is poorly developed, and the skin is fragile, very permeable, and easily traumatized by routine procedures such as cleansing or removal of adhesive tape. Injured skin provides a portal of entry for infectious agents. Similar defects are seen in the alimentary tract, where low levels of mucosal immunoglobulin A, high gastric pH, and short gastric emptying times increase the susceptibility of the newborn to gastrointestinal infections. Macrophages and neutrophils have reduced numbers as well as impaired chemotaxis and activity. Neonates have functioning B cells and T cells, but they are immature, which results in diminished effectiveness of their response. For example, B cells make antibodies to protein antigens but respond poorly to polysaccharide antigens, including the bacterial capsular polysaccharides of group B Streptococcus (GBS) and Haemophilus influenzae. In addition, their immune systems lack the immunologic memory that results from prior exposure to pathogens and from immunization. Maturational defects in T-cell function enhance the susceptibility of the newborn to intracellular pathogens such as Listeria, Toxoplasma, and Salmonella. In the first weeks of life, the newborn depends on passively transferred maternal antibody and the repertoire of antibodies received depends on maternal exposure. Because placental transfer of antibody occurs in the third trimester, infants born at <34 weeks have low levels of immunoglobulin G antibodies. As a result of a reduced capacity to fight infection, even viral respiratory infections, such as rhinovirus, can result in substantial morbidity and mortality in hospitalized neonates.



Sources of Infectious Agents and Modes of Transmission

The newborn may develop infection as a result of exposure to maternal flora during labor or delivery, or postpartum from maternal, hospital, or community sources. Postnatally, the hands of healthcare personnel (HCP) are the most common vehicles for transmission of potential pathogens in neonatal units.8,9 Nursery outbreaks of Staphylococcus aureus, Enterococcus, a variety of Gram-negative bacilli, and viruses have been attributed to hand transmission.1,10,11,12,13,14,15,16,17 In one study, Gram-negative bacilli were found on the hands of 75% of NICU personnel.18 Usually, hands are transiently contaminated, and hand hygiene removes the microorganisms and interrupts transmission.19 Occasionally, personnel who are persistent carriers of potential pathogens such as S aureus or group A Streptococcus (GAS) have been implicated in nursery outbreaks.20,21 Ophthalmologic exams for retinopathy of prematurity have been associated with the development of conjunctivitis, including outbreaks of adenoviral conjunctivitis.22,23

Patient care equipment may also serve as a vehicle for transmission. Multiple outbreaks have been associated with contaminated respiratory care equipment including ventilator circuits,24,25 laryngoscopes,26 balloons used for manual ventilation,27 and suction devices.28,29,30 Inadequate disinfection of rectal thermometers contributed to nursery outbreaks of Salmonella eimsbuettel31 and Enterobacter cloacae.32 Infusion of contaminated intravenous fluids, including total parental nutrition solutions and lipid emulsions, may result in bacteremia or meningitis.33,34,35,36,37,38,39,40,41 Exposure to contaminated topical preparations and medications, including contaminated eyewash,42 umbilical cord wash,43 and glycerin44 may also result in invasive infections. Use of contaminated ultrasound gel resulted in an outbreak of pyoderma in hospitalized neonates,45 while bathing practices have been linked in clusters of listeriosis46 and Stenotrophomonas infections.47

Hospitalized neonates are also at risk for food-borne infection. Powdered formula is not sterile, and feeding of reconstituted formula has been associated with Gram-negative bacteremia and meningitis.48 Expressed breast milk may be contaminated during collection,49,50,51 and both breast milk52,53,54 and formula55,56 may be contaminated during storage and handling. Feeding practices may also contribute to infection. A cluster of Elizabethkingia meningoseptica (formerly Flavobacterium meningosepticum) was linked to contamination of the formula preparation area and bottle stoppers.57 Cases of Cronobacter sakazakii (formerly Enterobacter sakazakii) have been linked to contaminated powdered infant formula.58


EPIDEMIOLOGY OF HAIS IN THE NICU

In general, infections not present or incubating at the time of admission are considered healthcare associated. A practical adaptation of this definition for newborns has been to define HAIs as those that present after 48 hours of age. This convention may result in misclassification of some infections, as some that result from perinatal exposure to maternal genital flora may not manifest until ≥48 hours. Likewise, failure to use aseptic technique for invasive procedures such as umbilical catheter placement may result in HAIs that manifest in <48 hours. Because of the difficulty in correctly classifying infections, the U.S. Centers for Disease Control and Prevention (CDC) has defined all neonatal infections, whether acquired during delivery or during hospitalization, as healthcare associated unless evidence indicates transplacental acquisition.59

Rates of HAIs in well newborn nurseries are low, ranging from 0.3 to 1.7 per 100 newborns.60,61,62 Short hospital stays and exposure to few invasive devices or procedures account for the low rates of infection. The difficulty of performing postdischarge surveillance for infection may lead to underrecognition of HAIs such as conjunctivitis and pustulosis. Outbreaks in newborn nurseries have been linked to vertical transmission from a mother to her infant with subsequent transmission to other infants, or occasionally transmission from sick HCP.63

Recent National Healthcare and Safety Network (NHSN) data show that nearly half (45%) of all pediatric HAIs occur in the NICU.64 The most commonly identified pathogens associated with HAIs in the NICU were coagulase-negative staphylococci (CoNS) (28%) and S aureus (25%). Antibiotic resistance rates were lower in the NICU compared with the pediatric intensive care unit (PICU). Rates of infection are inversely related to birth weight and gestational age (GA) with the highest rates for very low birth weight (VLBW) infants.65 According to data reported by the National Institute of Child Health and Human Development (NICHD) National Research Network over a 2-year period, 21% of VLBW infants developed late-onset sepsis.66 Reported rates of HAIs in NICUs have ranged from 6% to 25%,67,68,69,70 while a multicenter study in Europe reported rates of 7%.71 Lack of consistent definitions, heterogeneous patient populations, and variable exposure to invasive devices make comparison of these studies difficult. A 2001 point prevalence study of HAIs in 29 NICUs representing 19 states and the District of Columbia reported that 11.4% of patients developed an HAI.65 National prevalence studies from Spain72 and Norway73 yielded similar results, with reported rates of 16.7% and 14%, respectively. Rates of HAIs in neonates are 3-20 times higher in resource-limited countries.74 A 10-year prospective surveillance study of six NICUs in Brazil identified HAIs in 69% of admitted infants.75

Consistent with findings in other healthcare settings, HAIs in the NICU result in increased morbidity, mortality, length of stay, and healthcare costs. HAIs in the NICU have been found to double the risk of death.1,76 Bloodstream infections (BSIs) in hospitalized neonates result in significant mortality, 1.6% for CoNS, 10.5% for Gram-negative bacilli, and as high as 28% for antibiotic-resistant organisms.77,78 Studies have shown that neonates with HAIs had impaired growth and neurodevelopmental outcomes and increased risk of developing cerebral palsy and bronchopulmonary dysplasia.79,80,81,82 In addition, the median duration of hospitalization for neonates with NICU-acquired infections was significantly longer (88 vs 32 days).65 For VLBW infants, BSIs can prolong hospitalization by up to 10 days and increase healthcare costs by $50 000.83


DEVICE-ASSOCIATED HAIS


Central Line-Associated Bloodstream Infections

CVCs are frequently utilized in premature neonates to provide parenteral nutrition and medication administration with peripherally inserted central catheters (PICCs)
being the most commonly used CVCs in the NICU. Umbilical venous catheters and umbilical arterial lines, which are unique to the neonatal setting, are also utilized, especially in the first week of life to provide central access. The presence of a CVC is the most important risk factor associated with the development of a BSI in the NICU. Between 2011 and 2014 there were 15 538 central line-associated bloodstream infections (CLABSIs) reported to NHSN with 50.5% of these occurring in the NICU.64 The pooled mean CLABSI rates are higher for lower birth weights (BWs), 2.1 CLAB-SIs/1000 CVC-days (BW 750 g or less) vs 0.7 CLABSIs/1000 CVC-days (BW >2500 g).84 CoNS (28%), S aureus (25%), Enterococcus faecalis (8.4%), Escherichia coli (8.3%), and Klebsiella spp. (7%) are the most frequently identified pathogens causing CLABSIs in the NICU.64 Candida spp. was the cause of 7% of CLABSIs in this population.64

Although many of the risk factors associated with CLABSIs in neonates are similar to those in older children and adults, there are a few differences worth noting. The longer time that a CVC is in place increases the risk of a CLABSI. Unfortunately, neonates frequently require CVCs for prolonged periods of time.85 Umbilical catheterization for more than 5 days is recognized as an independent risk factor for sepsis.86 In one study, catheter duration of 10-21 days was associated with a 40-fold risk of Gram-negative BSIs in VLBW infants, while the risk was 90-fold with catheter duration of >21 days.87 In a retrospective cohort study in a single NICU, the incidence rate of CLABSIs increased by 14% by day during the first 18 days after PICC insertion. The trend reversed from days 19 to 35 after insertion, but after day 36, the incidence rate of CLABSIs increased by 33% per day. While identifying and removing CVCs once they are no longer necessary reduces the risk of CLABSIs, the prolonged CVC dwell times required in the NICU highlight the importance of meticulous catheter care. In addition to low birth weight and GA, mechanical ventilation86,88 and total parenteral nutrition88 are risk factors for the development of CLABSIs. In one study involving 3470 catheter days, sampling of blood through the central line and disconnection of the catheter increased the risk of CLABSIs.89 The importance of catheter location on the incidence of infection remains controversial. One study identified a higher rate of catheter-related sepsis in VLBW infants with femoral PICCs compared to those with nonfemoral PICCs (22.5% vs 12% or 10.9 vs 6.8 episodes/1000 catheter days).90 Another study found no difference in infection rates when PICCs placed in an upper extremity were compared to those placed in a lower extremity, although the pathogens associated with infections did vary by site.91,92 CoNS infections were more common in infants with upper extremity catheters, while more Gram-negative infections were diagnosed in children with lower extremity catheters. The skin of premature infants, which is more fragile and easily damaged, is another potential risk factor for CLABSIs in this population. Additionally, the immature gastrointestinal tract can result in translocation of pathogens into the bloodstream. Distortion of the premature neonatal microbiota has been associated with late-onset sepsis.92 The presence of an active intra-abdominal process has been identified as a significant risk factor resulting in a sixfold increase in CLABSIs in the NICU.93 Premature neonates with intra-abdominal pathology may represent a distinct risk subset similar to oncology patients with mucosal barrier injury.

Over the past few years, there have been significant reductions in CLABSIs. Recent NHSN data show decreased CLABSIs across all birth weight categories.94 Interventions to reduce CLABSIs have primarily focused on the insertion of the CVC and ongoing maintenance of the CVC. Organizations like the U.S. Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Society for Healthcare Epidemiology of America (SHEA) have developed evidence-based recommendations involving small groups of interventions designed to be implemented together (bundles) that focus on preventing infection before, during, and after insertion of the CVC.95 Key bundle components are listed in Table 29-1. When performed consistently, these
bundles have been shown to reduce CLABSIs.96,97 For the most part, these same bundles are applicable in the NICU. There are a few differences in CLABSI prevention in the NICU related to both insertion and maintenance practices that are worth noting.








TABLE 29-1 Recommended Practices Before, During, and After Insertion of a Central Venous Catheter for the Prevention of Central Line-Associated Bloodstream Infections in the NICU



















Before insertion:




  • Provide access to evidence-based indications for CVC insertion



  • Require initial and ongoing education and training of healthcare personnel involved in insertion, care, or maintenance of CVCs about CLABSI prevention



  • Bathe patients daily with a CHG preparation if >2 mo of agea


During insertion:




  • Use an insertion checklist



  • Use a kit or cart to ensure all supplies are available



  • Weigh patient-specific risks and benefits in choosing a CVC insertion site



  • Maximal sterile barrier precautions



  • Hand hygiene prior to insertion



  • Skin disinfection with chlorhexidine or povidone-iodinea



  • Empower staff to stop nonemergent procedure if sterile technique is not followed


After insertion:




  • Daily assessment and documentation of catheter needb



  • Disinfect all catheter hubs, needless connecters, and injection ports using friction prior to line entryc



  • Change the CVC dressing at least every 7 d for transparent dressings and every 2 d for gauze dressings. In the NICU to avoid dislodgement, consider changing dressings less frequently (eg, when soiled or nonocclusive)



  • Replace administration sets that are not used for blood products or lipids no more frequently than every 96 h



  • Replace administration sets used for blood products or lipids within 24 h of initiating the infusion


a Clinicians must weigh the risks and benefits of using CHG in infants under 2 months of age especially if preterm due to the potential for adverse skin reactions.

b When catheter used primarily for nutritional purposes, catheter removal considered when infant receiving ≥120 mL/kg/d enteral nutrition; discontinuation of intravenous lipids considered when infant receiving >2.5 g/kg/d enteral fat.

c Alcohol or chlorhexidine used.


CVC, central venous catheter; CHG, chlorhexidine gluconate.


Trained intravascular access teams are being increasingly utilized in NICUs to help standardize PICC placement as well as ongoing catheter care, such as dressing changes. In the NICU, the majority of these teams are nurse led. Implementation of dedicated teams focused on PICC insertion and maintenance have resulted in significant reductions in CLABSIs in the NICU.98,99 The skin at the insertion site should be disinfected prior to insertion, typically with CHG. Currently, CHG is not approved by the U.S. Food and Drug Administration (FDA) for use in premature infants or infants under two months of age, but there is growing evidence that CHG can be used safely in this population.100 This prompted the FDA to adjust the product label for CHG (2%) and isopropyl alcohol (70%), which now states “[u]se with care in premature infants or infants under two months of age. These products may cause irritation or chemical burns.”100 CHG use in neonates is discussed in greater detail later in the chapter. Prior to CVC insertion, guidelines recommend scrubbing the site for 30 seconds or longer and then allowing the skin to dry completely. In premature neonates with fragile skin, this could result in skin injury; therefore, care should be used in disinfecting the insertion site.

Given the long duration that CVCs remain in place in neonates, special attention to maintenance bundles is required. Contamination of catheter hubs has been shown to play a role in the majority of CLABSIs in the NICU.101 Thus, disinfection of the catheter hubs and connectors must be performed consistently. Connection sites should be vigorously scrubbed for at least five seconds using an alcoholic CHG preparation, 70% alcohol or povidone-iodine, and allowed to dry prior to accessing.102 A recent multicenter quality improvement project performed in tertiary NICUs examined the impact of different maintenance bundle elements on CLABSI reduction.103 The bundle elements significantly associated with reduced CLABSIs included hub-care compliance monitoring and sterile technique for tubing changes (hand hygiene, sterile gloves, mask, and sterile barrier under the catheter). The use of sterile tubing change decreased CLABSI rates by 0.51/1000 CVC days. Adding hub-care monitoring led to a decrease of 1.25 CLABSIs/1000 CVC days. An alternative to scrubbing the hub involves placing disinfectant caps containing 70% isopropyl alcohol on all unused hubs and connectors. At this time, there are no NICU-specific data, but their use in a trauma ICU resulted in a 40% decrease in CLABSIs.104 Another study showed that for every 30% increase in utilization of the maintenance checklist, there was a 16.5% decrease in the CLABSI rate.96 Skin protection is also a factor in CVC dressing changes for premature neonates. In general, guidelines recommend changing gauze dressings every two days and transparent dressing every seven days unless soiled, damp, or nonadherent.102 To reduce skin trauma or catheter dislodgement, some centers only change transparent dressings if they become soiled, damp, or nonadherent. Additional recommendations for the management of umbilical arterial and venous catheters, devices used exclusively in neonates, are listed in Table 29-2.








TABLE 29-2 Recommendations for the Management of Umbilical Catheters

























Remove and do not replace umbilical artery catheters if any of the following are present:




  • CLABSIs



  • Vascular insufficiency in lower extremities



  • Thrombosis


Remove and do not replace umbilical vein catheters if either of the following are present:




  • CLABSIs



  • Thrombosis


Replace umbilical venous catheters only in the setting of catheter malfunction


Cleanse umbilical insertion site with antiseptic before catheter insertion


Avoid tincture of iodine because of the potential effect on the neonatal thyroid


Avoid topical antibiotic ointments or creams at the catheter insertion site because of the potential to promote antibiotic resistance or fungal infections


Add low doses of heparin (0.25-1 U/mL) to fluids infused through umbilical artery catheters


Remove umbilical artery catheters after 5 d (or sooner if they are no longer needed)


Remove umbilical vein catheters after 14 d (or sooner if they are no longer needed or have not been managed aseptically)


Antimicrobial lock therapy is a promising strategy for the prevention of CLABSIs. Filling the lumen of a catheter with a supraphysiologic concentration of an antibiotic or agent such as ethanol may prevent or eliminate the bacterial colonization that ultimately results in CLABSIs. Current guidelines suggest that lock therapy could be useful in certain high-risk patients or those with recurrent infections. However, few studies have evaluated lock therapy in neonates. Vancomycin-heparin locks were studied in a prospective randomized double-blind trial in NICU patients. When definite and probable BSIs were considered, there were significantly fewer infections in the lock group (2.3 vs 17.8/1000 catheter days; relative risk 0.13: 95% confidence interval: 0.01-0.57).105 Similar results were observed in an Italian trial of a fusidic acid-heparin lock in neonates.106 To date, however, few centers employ antibiotic lock therapy for primary prevention of CLABSIs in NICU patients.

CHG is a frequent component of CLABSI prevention protocols outside the NICU. CHG is used for skin disinfection at the CVC insertion site, for CHG bathing to decrease bacterial colonization on the skin, and in CHG-impregnated sponges (eg, Biopatch) that further protect the CVC insertion site. CHG bathing in adult ICUs was associated with a 50% reduction in CLABSI rates.107,108,109 In a randomized trial in PICUs, there was a 48% decrease in CLABSI rates.110 In adults, the use of CHG-impregnated sponges at CVC insertion sites reduced CLABSI rates from 1.3 to 0.4/1000 CVC-days; however, a multicenter study in PICUs failed to demonstrate a significant reduction.97,111 The primary
concerns with CHG use in the NICU are the potential for skin irritation or chemical burns and systemic absorption. Published data about CHG use for CVC care in neonates are limited. In one study, 48 infants ≥1500 g BW and at least 7 days of age were randomized to 2% CHG or 10% povidone-iodine for preparation of catheter insertion sites and for use with dressing changes.112 Severe dermatitis did not occur in the CHG group. Cutaneous absorption of CHG was documented but was not associated with systemic toxicity. This small study was underpowered to show a difference in CLABSI or clinical sepsis. The enrolled infants were relatively mature (mean BW of 2000 g and 32-33 weeks of gestation). A study in less mature neonates did demonstrate CHG-related dermatitis. When an Australian NICU employed 2% aqueous CHG for central line insertion and maintenance, 4/26 infants <1000 g BW and <48 hours of age developed severe skin irritation (redness = 3; skin breakdown = 1).113 Nevertheless, a recent survey of neonatology training program directors confirms that off-label use of CHG is common in NICUs. Sixty-one percent of survey respondents reported using CHG in their NICUs.114 Despite this widespread use and evidence of systemic absorption, there have not been any documented neurologic adverse events. With the growing experience that suggests, with certain caveats, CHG can be used safely in infants under two months of age, the FDA revised its recommendations, stating CHG-impregnated cloths should be used with caution in this population.115 A recent Cochrane Database systematic review evaluated the effectiveness of CHG dressings compared to standard polyurethane dressings to prevent CLABSIs in the NICU. There was no significant difference in rates of sepsis or CLABSI.116 Use of a chlorhexidine-impregnated dressing has been associated with dermatitis in low birth weight neonates.117 Based on these data, in 2017, HICPAC updated its recommendations for use of CHG-impregnated dressings recommending against their use in premature neonates, although no recommendations were made for term neonates due to lack of sufficient evidence.118


Ventilator-Associated Pneumonia

Ventilator-associated pneumonia (VAP) is common in preterm infants, many of whom require prolonged ventilatory support. Recent NHSN data show that the majority of VAPs (63%) occur in the NICU.64 VAP is the second most common HAI in the NICU with rates ranging from 0.2 to 1.8 infections per 1000 ventilator days.119 In a prospective study, nearly 30% of infants born at <28 weeks of gestation developed VAP; infection was significantly associated with mortality.120 Not surprisingly, the rates of VAP reported through NHSN are consistently highest in infants of <1000 g birth weight.121 Pooled mean rates of VAP for level II/III NICUs reporting data to NHSN from 2006 to 2008 ranged from 0.6/1000 ventilator days in infants of >2500 g birth weight to 2.7/1000 ventilator days in infants of ≤ 750 g birth weight. More recently, the incidence of VAP in the NICU decreased. Between 2008 and 2012, the rate of VAP decreased from 1.6 to 0.6 per 1000 ventilator days.122 Risk factors for VAP in NICU patients include duration of mechanical ventilation, reintubation, treatment with opiates, and endotracheal suctioning.123 Other modes of assisted ventilation, including nasal continuous positive airway pressure, have been associated with the development of healthcare-associated pneumonia, albeit at lower rates than those associated with mechanical ventilation.124

The most common pathogen identified is S aureus (24.2%).64 Gram-negative microorganisms are thought to cause at least 30% of VAP episodes, but a specific microbiologic diagnosis is often difficult unless there is secondary bacteremia.65,125 Endotracheal cultures are rarely useful in the diagnosis of VAP because the respiratory tract of the intubated newborn rapidly becomes colonized with mixed Gram-positive flora by the second week of mechanical ventilation, and Gram-negative microorganisms after the fourth week.126,127 The presence of purulence in a specimen suctioned from the endotracheal tube of a mechanically ventilated neonate has a poor positive predictive value for respiratory tract infection, including pneumonia and tracheitis.127

The true burden of VAP remains unclear, because the diagnosis is difficult in NICU infants. Ultimately, many infants are treated empirically for presumed pulmonary infection. While NHSN surveillance definitions for VAP include criteria for infants <1 year of age, these definitions have not been validated in premature neonates. Premature neonates, especially those on prolonged ventilatory support, frequently have underlying chronic lung disease. Comorbid conditions such as bronchopulmonary dysplasia may mimic the clinical and radiographic features of VAP.128 Detecting new persistent or progressive infiltrates overlaid upon underlying chronic lung changes is difficult. Developing accurate criteria for VAP in the NICU population remains a challenge. In attempt to improve the validity of VAP diagnosis, the CDC expanded the adult surveillance definition for VAP in 2013 to include other related complications and was termed ventilator-associated events (VAE).129 The VAE criteria are discussed in more depth in Chapter 16 Healthcare-Associated Pneumonia and VAE.

Applying these definitions in children, especially neonates, presents a number of challenges. Positive end expiratory pressure (PEEP) changes, which is a criterion used in the adult definitions, may not reflect changes in ventilation and oxygenation in children as well as mean airway pressure (MAP).130 In addition, the adult definition excludes high frequency ventilation, which is more commonly used in children. Temperature changes may be difficult to detect in neonates who are in temperature-regulated incubators. Finally, the white blood cell count definitions used in adults may not be appropriate in children and neonates. Recently, a pediatric VAE definition was developed.131 Similar to the adult definition, there are three nested categories. Pediatric ventilator-associated condition (VAC) includes at least two days of increased MAP by at least 4 cm H2O or fraction of inspired oxygen (FiO2) by at least 0.25 after a period of improvement or stability. Pediatric VAE with antimicrobial use (AVAC) removes the temperature and WBC criteria and is based on whether antibiotics are given for at least four calendar days. The addition of a positive diagnostic test for a respiratory infection to AVAC meets the criteria for a possible VAP (PVAP) in the pediatric definition. Comparing pediatric VAE definitions to NHSN VAP definitions shows poor correlation with only 6% overlap for VAC and 16% overlap for PVAP.131 In one study, children in the NICU and PICU with VACs were found to have higher mortality rates and longer durations of ventilation, ICU stays, and hospitalization.130


At this time, there are no published guidelines for VAE prevention. Recommendations for the prevention of VAP in children and adults have been published, although not all of the recommended strategies are applicable for NICU patients.132 For example, elevation of the head of the bed to 30-45 degrees is not feasible in a 1000-g infant. Updated guidelines from SHEA and Infectious Diseases Society of America (IDSA) for the prevention of VAP in acute care hospitals include evidence-based recommendations for preterm neonates.133 Basic practices encompass strategies with minimal associated risk that may potentially lower VAP rates. These include use of noninvasive methods of ventilation to avoid intubation; minimizing the duration of mechanical ventilation; when possible, managing patients without sedation, regularly assessing readiness to extubate; avoiding unplanned extubations; providing regular oral care with sterile water; and minimizing breaks in the ventilator circuit and only changing the ventilator circuit when soiled or malfunctioning. Additional strategies that may be implemented that have minimal risk but unknown benefit include positioning the patient in either the lateral recumbent position or reverse Trendelenburg position or using closed in-line suctioning (Table 29-3).

There are a number of strategies that are not recommended for preterm neonates for a variety of reasons. Use of antiseptics for oral care is not recommended as the impact on normal flora and the potential for systemic absorption is unknown. Use of histamine H2 receptor antagonists,134,135 prophylactic antibiotics,136,137 and spontaneous breathing trials138,139 is not recommended due to the potential risk of harm. Finally, the use of probiotics in neonates is not FDA approved, and endotracheal tubes with subglottic suction drains or silver-coated endotracheal tubes are not commercially available in appropriate sizes for neonates.

Only gold members can continue reading. Log In or Register to continue

Jun 8, 2021 | Posted by in INFECTIOUS DISEASE | Comments Off on Infection Prevention Issues Unique to Newborns and the Neonatal Intensive Care Unit
Premium Wordpress Themes by UFO Themes